Founded in 2001 and named after the regulatory code governing the food and drug industries in the United States, Title21 Health Solutions is the world’s largest and most highly specialized software provider of electronic quality management systems and workflow solutions to cell & gene therapy labs.

Title21’s clients include globally preeminent hospital and research institutions, including the Mayo Clinic, Memorial Sloan Kettering Cancer Center, Stanford University, Kaiser Permanente, and the University of Pennsylvania Health System.

The fast-growing cell & gene therapy industry is transforming the treatment of life-threatening conditions including genetic disorders such as spinal muscular atrophy, as well as diseases caused by vital infection, including COVID-19.

  • Investment date

    2022

  • Sector

    Health Technologies & Software

  • Transaction type

    Buy-Out

  • Growth theme

    Customer expansion, internationalization

  • Location

    United States